Literature DB >> 15757463

Ocular bacterial infections: current and future treatment options.

Regis P Kowalski1, Deepinder K Dhaliwal.   

Abstract

In this article, common ocular bacterial infections are reviewed, examining bacterial pathogens, antibiotics and antibacterial resistant trends in light of current and future treatment options. Ophthalmologists are fortunate to be able to choose between an array of old and new antibiotics in order to treat bacterial ocular infections. Ophthalmic infections are primarily treated with topical antibiotics applied directly to the eye. Since there are no in vitro susceptibility standards for interpreting ocular bacterial susceptibility, systemic standards are used. There is no immediate need for new ophthalmic antibiotics, but increasing resistance is being seen with the widely used fluoroquinolone antibiotics.

Entities:  

Mesh:

Year:  2005        PMID: 15757463

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  5 in total

1.  Effect of emergence of fluoroquinolone resistance on intrinsic expression of P-glycoprotein phenotype in corneal epithelial cells.

Authors:  Megha Barot; Mitan R Gokulgandhi; Megan Haghnegahdar; Pranjali Dalvi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2011-08-10       Impact factor: 2.671

2.  Design of Topical Moxifloxacin Mucoadhesive Nanoemulsion for the Management of Ocular Bacterial Infections.

Authors:  Ahmed Adel Ali Youssef; Ruchi Thakkar; Samir Senapati; Poorva H Joshi; Narendar Dudhipala; Soumyajit Majumdar
Journal:  Pharmaceutics       Date:  2022-06-12       Impact factor: 6.525

Review 3.  Bacterial profile of ocular infections: a systematic review.

Authors:  Mebrahtu Teweldemedhin; Hailay Gebreyesus; Ataklti Hailu Atsbaha; Solomon Weldegebreal Asgedom; Muthupandian Saravanan
Journal:  BMC Ophthalmol       Date:  2017-11-25       Impact factor: 2.209

4.  Ocular bacterial infections at Quiha Ophthalmic Hospital, Northern Ethiopia: an evaluation according to the risk factors and the antimicrobial susceptibility of bacterial isolates.

Authors:  Mebrahtu Teweldemedhin; Muthupandian Saravanan; Araya Gebreyesus; Dawit Gebreegziabiher
Journal:  BMC Infect Dis       Date:  2017-03-14       Impact factor: 3.090

5.  Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.

Authors:  Joseph S Bertino
Journal:  Clin Ophthalmol       Date:  2009-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.